Skip to main content
SpringerLink
Log in

Quality of life impairment syndrome in schizophrenia

  • Chapter
Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders

Abstract

Patients with schizophrenia exhibit an exceedingly wide range of symptoms, and a broad spectrum of cognitive impairments. In addition, it has become increasingly apparent that the disorder is, to variable degrees, accompanied by quality of life impairments. This chapter addresses the question of whether the health-related quality of life (HRQL) impairment or deficit is a syndrome in schizophrenia. Therefore, first, we discuss what the general and domain-specific HRQL impairments are. Then, we address distressing and protective factors, and a factor structure of HRQL impairment. The literature, as well as new and previously published findings from the Shaar Menashe Longitudinal Study of Quality of Life will be presented in detail.

We argue that HRQL deficit is highly prevalent and fairly marked in schizophrenia patients: 49% of the patients are clinically severely impaired regarding general life quality, 42% - in general activities, 39% - in subjective feelings, 30% - in both leisure time activities and social relationships. The HRQL impairment has been observed before individuals exhibit the signs and psychotic symptoms of schizophrenia; it is relatively stable throughout the course of the illness. HRQL impairment syndrome appears to be relatively independent of symptomatology and neurocognitive deficit. Finally, the authors suggest that impairment in general and the domain-specific quality of life in particular is sufficiently reliable, stable, and specific enough syndromes to warrant inclusion in the diagnostic criteria for schizophrenia. Limitations in the current knowledge in this area are identified, and suggestions for future research are provided

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ritsner M, Kurs R. Impact of antipsychotic agents and their side effects on the quality of life in schizophrenia. Expert Review and Pharmacoeconomic Outcomes Research 2002; 2: 89–98.

    Google Scholar 

  2. Ritsner M, Kurs R. Quality of life outcomes in mental illness: schizophrenia, mood and anxiety disorders. Expert Review and Pharmacoeconomic Outcomes Research 2003; 3: 189–199.

    Article  Google Scholar 

  3. Ritsner, M., Kurs, R. Quality-of-Life Impairment in Severe Mental Illness: Focus on Schizoaffective Disorders. In: William H. Murray, ed. Schizoaffective Disorder: New Research. NOVA Publishers, NY, 2006, pp. 69–107.

    Google Scholar 

  4. Awad AG, Voruganti LN. Impact of atypical antipsychotics on quality of life in patients with schizophrenia. CNS Drugs. 2004, 18:877–893.

    Article  PubMed  CAS  Google Scholar 

  5. Lambert M, Naber D. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs. 2004; (18 Suppl) 2:5–17.

    Article  Google Scholar 

  6. Hansson L.Determinants of quality of life in people with severe mental illness. Acta Psychiatr Scand 2006; (429 suppl):46–50.

    Article  Google Scholar 

  7. Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: an instrument for rating the schizophrenic deficit scale. Schizophrenia Bull. 1984; 10: 388–398.

    CAS  Google Scholar 

  8. Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry 1997;154:99–105.

    PubMed  CAS  Google Scholar 

  9. Voruganti L, Heslegrave R, Awad AG, Seeman MV. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 1998; 28: 165–172.

    Article  PubMed  CAS  Google Scholar 

  10. Whitty P, Browne S, Clarke M, McTigue O, Waddington J, Kinsella T, Larkin C, O’Callaghan E. Systematic comparison of subjective and objective measures of quality of life at 4-year follow-up subsequent to a first episode of psychosis. J Nerv Ment Dis. 2004; 192: 805–809.

    Article  PubMed  Google Scholar 

  11. Ritsner M, Modai I, Endicott J, et al. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000; 61: 880–889.

    Article  PubMed  CAS  Google Scholar 

  12. Ritsner M, Ponizovsky A, Endicott J, et al. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study. Eur Neuropsychopharmacol 2002; 12: 31–38.

    Article  PubMed  CAS  Google Scholar 

  13. Ritsner M, Modai I, Kurs R, et al. Subjective Quality of Life Measurements in Severe Mental Health Patients: Measuring Quality of Life of Psychiatric Patients: Comparison Two Questionnaires. Quality Life Research 2002; 11: 553–561.

    Article  CAS  Google Scholar 

  14. Ponizovsky AM, Grinshpoon A, Levav I, Ritsner MS. Life satisfaction and suicidal attempts among persons with schizophrenia. Comprehensive Psychiatry 2003; 44: 442–447.

    Article  PubMed  Google Scholar 

  15. Ritsner M, Kurs R, Gibel A, et al. Predictors of quality of life in major psychoses: a naturalistic follow-up study. Journal of Clinical Psychiatry 2003; 64: 308–315.

    Article  PubMed  Google Scholar 

  16. Ritsner M, Ben-Avi I, Ponizovsky A, et al. Quality of life and coping with schizophrenia symptoms. Quality of Life Research 2003; 12: 1–9.

    Article  PubMed  CAS  Google Scholar 

  17. Ritsner M. Predicting changes in domain-specific quality of life of schizophrenia patients. J Nerv Ment Dis 2003; 191: 287–294.

    Article  PubMed  Google Scholar 

  18. Ritsner, M., Farkas, H., Gibel, A. Satisfaction with quality of life varies with temperament types of patients with schizophrenia. Journal of Nervous and Mental Disease 2003; 191: 668–674.

    Article  PubMed  Google Scholar 

  19. Ritsner M, Kurs R, Ponizovsky A, Hadjez J. Perceived quality of life in schizophrenia: relationships to sleep quality. Quality of Life Research 2004; 13: 783–791.

    Article  PubMed  Google Scholar 

  20. Ritsner, M., Perelroyzen, G., Kurs, R., et al. Quality of life outcomes in schizophrenia patients treated with atypical and typical antipsychotic agents: A naturalistic comparative study. International Clinical Psychopharmacology 2004; 24: 582–591.

    Article  CAS  Google Scholar 

  21. Ritsner M, Perelroyzen G, Ilan H, Gibel A. Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice: a naturalistic comparative study. J Clin Psychopharmacol. 2004; 24: 245–54.

    Article  PubMed  Google Scholar 

  22. Ritsner M, Susser E. Temperament types are associated with weak self-construct, elevated distress and emotion-oriented coping in schizophrenia: evidence for a complex vulnerability marker? Psychiatry Res. 2004; 128: 219–28.

    Article  PubMed  Google Scholar 

  23. Kurs R, Farkas H, Ritsner M. Quality of life and temperament factors in schizophrenia: comparative study of patients, their siblings and controls. Quality of Life Research 2005; 14: 433–440.

    Article  PubMed  Google Scholar 

  24. Ritsner M, Kurs R, Gibel A, Ratner Y, Endicott J. Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Qual Life Res. 2005; 14: 1693–703.

    Article  PubMed  Google Scholar 

  25. Ritsner M, Kurs R, Ratner Y, Gibel A. Condensed version of the Quality of Life Scale for schizophrenia for use in outcome studies. Psychiatry Res. 2005; 135: 65–75.

    Article  PubMed  Google Scholar 

  26. Ritsner MS, Ratner Y. The long-term changes in coping strategies in schizophrenia: temporal coping types. J Nerv Ment Dis. 2006; 194: 261–267.

    Article  PubMed  Google Scholar 

  27. Ritsner M, Gibel A, Ratner Y. Determinants of Changes in Perceived Quality of Life in the Course of Schizophrenia. Quality of Life Research 2006; 15: 515–526.

    Article  PubMed  Google Scholar 

  28. Ritsner MS, Gibel, A. The effectiveness and predictors of response to antipsychotic agents to treat impaired quality of life in schizophrenia: a 12-month naturalistic follow-up study with implications for confounding factors, antidepressants, anxiolytics, and mood stabilizers. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006;30:1442–1452 .

    Article  CAS  Google Scholar 

  29. Lehman, A. F. The well-being of chronic mental patients: assessing their quality of life. Archives of General Psychiatry 1983; 40:369–373.

    PubMed  CAS  Google Scholar 

  30. Sciolla A, Patterson TL, Wetherell JL, et al. Functioning and well-being of middle-aged and older patients with schizophrenia: measurement with the 36-item short-form (SF-36) health survey. Am J Geriatr Psychiatry. 2003; 11: 629–637.

    Article  PubMed  Google Scholar 

  31. Gorna K, Jaracz K, Rybakowski F. Objective and subjective quality of life in schizophrenic patients after a first hospitalization. Rocz Akad Med Bialymst. 2005; (50 Suppl) 1:225–7.

    Google Scholar 

  32. Law CW, Chen EY, Cheung EF, Chan RC, Wong JG, Lam CL, Leung KF, Lo MS. Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia. Qual Life Res. 2005;14:1803–1811.

    Article  PubMed  CAS  Google Scholar 

  33. Kentros MK, Terkelsen K, Hull J, et al.The relationship between personality and quality of life in persons with schizoaffective disorder and schizophrenia. Quality of Life Research, 1997, 6,118–22.

    Article  PubMed  CAS  Google Scholar 

  34. Tollefson GD, Andersen SW. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life? Journal of Clinical Psychiatry 1999; (60 Suppl)5:23–29.

    Google Scholar 

  35. Rudolf H, Priebe S. Subjective quality of life in female in-patients with depression: a longitudinal study. International Journal of Social Psychiatry 1999; 45: 238–246.

    Article  PubMed  CAS  Google Scholar 

  36. Koivumaa-Honkanen HT, Honkanen R, Antikainen R,et al. Self-reported life satisfaction and treatment factors in patients with schizophrenia, major depression and anxiety disorder. Acta Psychiatrica Scandinavica 1999; 99: 377–384.

    PubMed  CAS  Google Scholar 

  37. Wittchen HU, Carter RM, Pfister H, et al. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol. 2000; 15: 319–328.

    PubMed  CAS  Google Scholar 

  38. Bystritsky A, Liberman RP, Hwang S, et al. Social functioning and quality of life comparisons between obsessive-compulsive and schizophrenic disorders. Depress Anxiety. 2001; 14: 214–218.

    Article  PubMed  CAS  Google Scholar 

  39. Bobes J, Gonzalez MP, Bascaran MT, et al. Quality of life and disability in patients with obsessive-compulsive disorder. Eur Psychiatry 2001;16:239–245.

    Article  PubMed  CAS  Google Scholar 

  40. Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. American Journal of Psychiatry 2005; 162: 1171–1178.

    Article  PubMed  Google Scholar 

  41. Stone WS, Faraone SV, Seidman LJ, et al. Concurrent validation of schizotaxia: a pilot study. Biol Psychiatry 2001; 50: 434–440.

    Article  PubMed  CAS  Google Scholar 

  42. Browne S, Clarke M, Gervin M, et al. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000; 176: 173–176.

    Article  PubMed  CAS  Google Scholar 

  43. Melle I, Haahr U, Friis S, et al. Reducing the duration of untreated first-episode psychosis - effects on baseline social functioning and quality of life. Acta Psychiatr Scand. 2005; 112: 469–473.

    Article  PubMed  CAS  Google Scholar 

  44. Czernikiewicz A, Gorecka J, Kozak-Sykala A. [Premorbid adjustment and quality of life in schizophrenia]. Pol Merkuriusz Lek. 2005; 19: 659–662.

    Google Scholar 

  45. Erickson DH, Beiser M, Iacono WG, et al. The role of social relationships in the course of first-episode schizophrenia and affective psychosis. Am J Psychiatry. 1989; 146: 1456–1461.

    PubMed  CAS  Google Scholar 

  46. Bechdolf A, Pukrop R, Kohn D, et al. Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls. Schizophr Res. 2005; 79: 137–143.

    Article  PubMed  Google Scholar 

  47. Priebe S, Roeder-Wanner UU, Kaiser W. Quality of life in first-admitted schizophrenia patients: a follow-up study. Psychological Medicine 2000; 30: 225–230.

    Article  PubMed  CAS  Google Scholar 

  48. Tempier R, Mercier C, Leouffre P, Caron J. Quality of life and social integration of severely mentally ill patients: a longitudinal study. Journal of Psychiatry and Neuroscience 1997; 22: 249–255.

    PubMed  CAS  Google Scholar 

  49. Skantze K. Subjective quality of life and standard of living: a 10-year follow-up of out-patients with schizophrenia. Acta Psychiatrica Scandinavica 1998; 98: 390–399.

    PubMed  CAS  Google Scholar 

  50. Hoffmann K, Kaiser W, Isermann M, Priebe S. [How does the quality of life of long-term hospitalized psychiatric patients change after their discharge into the community?] Gesundheitswesen 1998; 60: 232–238.

    PubMed  CAS  Google Scholar 

  51. Henkel H, Schmitz M, Berghofer G. [Quality of life of the mentally ill] Wiener medizinische Wochenschrift 2000; 150: 32–36.

    PubMed  CAS  Google Scholar 

  52. Malla AK, Norman RM, McLean TS, McIntosh E. Impact of phase-specific treatment of first episode of psychosis on Wisconsin Quality of Life Index (client version). Acta Psychiatrica Scandinavica 2001;103:355–361.

    Article  CAS  Google Scholar 

  53. Ruggeri M, Lasalvia A, Tansella M, et al. Heterogeneity of outcomes in schizophrenia. 3-year follow-up of treated prevalent cases. Br J Psychiatry 2004; 184: 48–57.

    Article  PubMed  Google Scholar 

  54. Hansson L, Middelboe T, Merinder L, et al. Predictors of subjective quality of life in schizophrenic patients living in the community. A Nordic multicentre study. : International Journal of Social Psychiatry 1999; 45: 247–258.

    Article  PubMed  CAS  Google Scholar 

  55. Hansson L, Eklund M, Bengtsson-Tops A. The relationship of personality dimensions as measured by the temperament and character inventory and quality of life in individuals with schizophrenia or schizoaffective disorder living in the community. Quality of Life Research 2001; 10: 133–139.

    Article  PubMed  CAS  Google Scholar 

  56. Eklund M, Backstrom M, Hansson L. Personality and self-variables: important determinants of subjective quality of life in schizophrenia out-patients. Acta Psychiatrica Scandinavica 2003; 108: 134–143.

    Article  PubMed  CAS  Google Scholar 

  57. Eklund M, Hansson L, Bengtsson-Tops A. The influence of temperament and character on functioning and aspects of psychological health among people with schizophrenia. Eur Psychiatry 2004; 19: 34–41.

    Article  PubMed  Google Scholar 

  58. Eklund M, Backstrom M. A model of subjective quality of life for outpatients with schizophrenia and other psychoses. Quality of Life Research 2005; 14: 1157–1168.

    Article  PubMed  Google Scholar 

  59. Lazarus, R. S., & Folkman, S. Stress, appraisal, and coping. New York: Springer. 1984.

    Google Scholar 

  60. Dohrenwend BP, Shrout PE, Egri G, Mendelsohn FS. Nonspecific psychological distress and other dimensions of psychopathology. Measures for use in the general population. Arch Gen Psychiatry 1980; 37: 1229–1236.

    PubMed  CAS  Google Scholar 

  61. Derogatis LR, Coons HL. Self-report measures of stress. In: Goldberger L and Breznittz S, ed. Handbook of Stress: Theoretical and Clinical Aspects. Second edition. The Free Press, New York,pp, 200–233 1993; pp, 200–233. 1993.

    Google Scholar 

  62. Coyne JC, Schwenk TL. The realtionship of distress to mood disturbance in primary care and psychiatric populations. J Consult Clin Psychol 1997; 65: 161–168.

    Article  PubMed  CAS  Google Scholar 

  63. Ritsner M, Modai I, Ponizovsky A. The Talbieh Brief Distress Inventory: validation for use with psychiatric patients. Compr Psychiatry 2002; 2: 144–163.

    Google Scholar 

  64. Norman RMG, Malla AK: Stressful life events and schizophrenia, I: a review of the research. Br J Psychiatry 1993; 162:161–166.

    PubMed  CAS  Google Scholar 

  65. Myin-Germeys, I., Jim van, O.S., Schwartz, J.E., Stone, A.A., Delespaul, P.A. Emotional reactivity to daily life stress in psychosis. Archives of General Psychiatry 2001; 58: 1093–1208.

    Article  Google Scholar 

  66. Ritsner M. The attribution of somatization in schizophrenia patients: a naturalistic follow-up study. J Clin Psychiatry. 2003; 64: 1370–8.

    Article  PubMed  Google Scholar 

  67. Selten JP, Wiersma D, van den Bosch RJ. Distress attributed to negative symptoms in schizophrenia. Schizophr Bull 2000; 26: 737–744.

    PubMed  CAS  Google Scholar 

  68. Fakhoury WK, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol 2001; 16: 153–1623.

    Article  CAS  Google Scholar 

  69. Caron J, Lecomte Y, Stip E, Renaud S. Predictors of quality of life in schizophrenia. Community Ment Health J. 2005; 41: 399–417.

    Article  PubMed  Google Scholar 

  70. Awad AG, Lapierre YD, Angus C, Rylander A. Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. Journal of Psychiatry and Neuroscience 1997; 22: 244–248.

    PubMed  CAS  Google Scholar 

  71. Lasalvia A, Ruggeri M, Santolini N. Subjective quality of life: its relationship with clinician-rated and patient-rated psychopathology. The South-Verona Outcome Project 6.Psychotherapy and Psychosomatics 2002; 71: 275–284.

    Article  PubMed  Google Scholar 

  72. Lobana A, Mattoo SK, Basu D, Gupta N. Quality of life in schizophrenia in India: comparison of three approaches. Acta Psychiatrica Scandinavica 2001; 104: 51–55.

    Article  PubMed  CAS  Google Scholar 

  73. Hooley JM, Campbell C. Control and controllability: 462 beliefs and behavior in high and low expressed emotion relatives. Psychol Med 2002; 32:1091–1099.

    Article  PubMed  Google Scholar 

  74. Mubarak AR, Barber JG. Emotional expressiveness and the quality of life of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2003; 38: 380–384.

    PubMed  CAS  Google Scholar 

  75. Guillem F, Bicu M, Semkovska,M, Debruille . The dimensional symptom structure of schizophrenia and its association with temperament and character. Schizophrenia Research 2002; 56: 137–147.

    Article  PubMed  Google Scholar 

  76. Szoke, A., Schurhoff, F., Ferhadian, N., et al.Temperament in schizophrenia: a study of the tridimensional personality questionnaire (TPQ). European Psychiatry 2002; 17: 379–383.

    Article  PubMed  Google Scholar 

  77. Diener E, Diener M. Cross-cultural correlates of life satisfaction and self-esteem. J Pers Soc Psychol. 1995; 68: 653–663.

    Article  PubMed  CAS  Google Scholar 

  78. Roe D. A prospective study on the relationship between self-esteem and functioning during the first year after being hospitalized for psychosis. J Nerv Ment Dis. 2003; 191: 45–9.

    Article  PubMed  Google Scholar 

  79. Gureje O, Harvey C, Herrman H. Self-esteem in patients who have recovered from psychosis: profile and relationship to quality of life. Aust N Z J Psychiatry. 2004; 38: 334–338.

    Article  PubMed  Google Scholar 

  80. Zissi A, Barry MM, Cochrane R. A mediational model of quality of life for individuals with severe mental health problems. Psychological Medicine 1998; 28: 1221–1230.

    Article  PubMed  CAS  Google Scholar 

  81. Ruggeri M, Bisoffi G, Fontecedro L, Warner R. Subjective and objective dimensions of quality of life in psychiatric patients: a factor analytical approach: The South Verona Outcome Project 4. British Journal of Psychiatry 2001; 178: 268–275.

    Article  PubMed  CAS  Google Scholar 

  82. Jerusalem M, Schwarzer R. Self-efficacy as a resource factor in stress appraisal processes. In R. Schwarzer (Ed.), Self-efficacy: Thought control of action. Hemisphere, Washington, DC pp. 195–213, 1992.

    Google Scholar 

  83. Strous, RD, Ratner, Y, Gibel, A, Ponizovsky, A, Ritsner, M. Longitudinal assessment of coping abilities at exacerbation and stabilization in schizophrenia. Comprehensive Psychiatry 2005; 46: 167–175.

    Article  PubMed  Google Scholar 

  84. Endler NS, Parker JDA, Summerfeldt LJ. Coping with health problems: Conceptual and methodological issues. Can J Behav Sci 1993; 25: 384–399.

    Article  Google Scholar 

  85. Lazarus RS. Coping theory and research: past, present, and future. Psychosom Med 55:234–247. 1993.

    PubMed  CAS  Google Scholar 

  86. Endler NS, Parker JD. Multidimensional assessment of coping: a critical evaluation. Journal of Personality and Social Psychology 1990; 58: 844–854.

    Article  PubMed  CAS  Google Scholar 

  87. Wilder-Willis, K.E., Shear, P.K., Steffen, J.J., Borkin, J. The relationship between cognitive dysfunction and coping abilities in schizophrenia. Schizophrenia Research 2002; 55: 259–267.

    Article  PubMed  Google Scholar 

  88. Higgins JE, Endler NS. Coping, life stress and psychological and somatic distress. European Journal of Personality 1995; 9: 253–270.

    Article  Google Scholar 

  89. Lysaker PH, Bryson GJ, Marks K, Greig TC, Bell MD. Coping style in schizophrenia: associations with neurocognitive deficits and personality. Schizophrenia Bulletin 2004; 30: 113–121.

    PubMed  Google Scholar 

  90. Bengtsson-Tops A, Hansson L. Quantitative and qualitative aspects of the social network in schizophrenic patients living in the community. Relationship to sociodemographic characteristics and clinical factors and subjective quality of life. International Journal of Social Psychiatry 2001; 47: 67–77.

    Article  PubMed  CAS  Google Scholar 

  91. Young , K.M. Factors predicting overall life satisfaction for people with long-term mental illness factors. International Journal of Psychosocial Rehabilitation. 2004; 9:23–35.

    Google Scholar 

  92. Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62: 975–83.

    Article  PubMed  Google Scholar 

  93. Ho BC, Andreasen NC, Flaum M, et al. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000; 157: 808–815.

    Article  PubMed  CAS  Google Scholar 

  94. Harris MG, Henry LP, Harrigan SM, et al. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res. 2005; 79: 85–93.

    Article  PubMed  Google Scholar 

  95. Malla A, Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull. 2005; 31: 650–671.

    Article  PubMed  Google Scholar 

  96. Sands JR, Harrow M. Depression during the longitudinal course of schizophrenia. Schizophr Bull. 1999; 25: 157–71.

    PubMed  CAS  Google Scholar 

  97. Packer S, Husted J, Cohen S, Tomlinson G. Psychopathology and quality of life in schizophrenia. Journal of Psychiatry and Neuroscience 1997; 22: 231–234.

    PubMed  CAS  Google Scholar 

  98. Fitzgerald PB, Williams CL, Corteling N, et al. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatrica Scandinavica 2001;103:387–392.

    Article  PubMed  CAS  Google Scholar 

  99. Smith KW, Avis NE, Assmann SF. Distinguishing between quality of life and health status in quality of life research: A meta-analysis. Quality of Life Research: International Journal of Quality of Life Aspects Treatment, Care and Rehabilitation 1999; 8:447–459.

    CAS  Google Scholar 

  100. Huppert JD, Smith TE. Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor. Journal of Nervous and Mental Disease 2001; 189: 669–675.

    Article  PubMed  CAS  Google Scholar 

  101. Huppert JD, Weiss KA, Lim R, et al. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophrenia Research 2001; 51: 171–180.

    Article  PubMed  CAS  Google Scholar 

  102. Hofer A, Kemmler G, Eder U, et al. Quality of life in schizophrenia: The impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry 2004; 65: 932–939.

    PubMed  Google Scholar 

  103. Braga RJ, Mendlowicz MV, Marrocos RP, Figueira IL.Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. J Psychiatr Res. 2005; 39: 409–14.

    Article  PubMed  Google Scholar 

  104. Karow A, Moritz S, Lambert M, et al. PANSS syndromes and quality of life in schizophrenia. Psychopathology. 2005; 38: 320–326.

    Article  PubMed  CAS  Google Scholar 

  105. Huppert JD, Smith TE. Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms. CNS Spectr. 2005;10:721–31.

    PubMed  Google Scholar 

  106. Wetherell JL, Palmer BW, Thorp SR, et al. Anxiety symptoms and quality of life in middle-aged and older outpatients with schizophrenia and schizoaffective disorder. Journal of Clinical Psychiatry 2003; 64: 1476–1482.

    Article  PubMed  Google Scholar 

  107. Galletly CA, Clark CR, McFarlane AC, Weber DC. Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine. Psychiatry Res 1997; 72: 161–166.

    Article  PubMed  CAS  Google Scholar 

  108. Kaiser W, Priebe S, Barr W, et al. Profiles of subjective quality of life in schizophrenic in- and out-patient samples. Psychiatry Research 1997; 66: 153–166.

    Article  PubMed  CAS  Google Scholar 

  109. Palmer BW, Heaton RK, Paulsen JS, Kuck J, Braff D, Harris MJ, Zisook S,Jeste DV. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 1997;11:437–446.

    Article  PubMed  CAS  Google Scholar 

  110. Heslegrave RJ, Awad AG, Voruganti LN. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci 1997; 22: 235–243.

    PubMed  CAS  Google Scholar 

  111. Dickerson FB, Ringel NB, Parente. Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand 1998; 98: 124–127.

    PubMed  CAS  Google Scholar 

  112. Kaiser W. Cognitive effects of antipsychotics in schizophrenia and relationship to quality of life. British Journal of Psychiatry 2000; 176: 92–93.

    Article  PubMed  CAS  Google Scholar 

  113. McDermid Vaz SA, Heinrichs RW. Schizophrenia and memory impairment: evidence for a neurocognitive subtype. Psychiatry Research, 2002, 113, 93–105.

    Article  PubMed  Google Scholar 

  114. Sota TL, Heinrichs RW. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics. Compr Psychiatry. 2004; 45: 415–21.

    Article  PubMed  Google Scholar 

  115. Alptekin K, Akvardar Y, Kivircik Akdede BB, et al. Is quality of life associated with cognitive impairment in schizophrenia? Progress in Neuropsychopharmacology and Biological Psychiatry 2005; 29: 239–44.

    Article  Google Scholar 

  116. Wegener S, Redoblado-Hodge MA, Lucas S, et al. Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust N Z J Psychiatry. 2005; 39: 487–492.

    Article  PubMed  Google Scholar 

  117. Ritsner, MS. Predicting quality of life impairment in chronic schizophrenia from cognitive variables. Quality of Life Research (2007; in press).

    Google Scholar 

  118. Amador, X., Strauss, D., Yale, S., Gorman, J. 1991. Awareness of illness in schizophrenia. Schizophrenia Bulletin 1991; 17: 113–132.

    CAS  Google Scholar 

  119. Browne S, Garavan J, Gervin M, et al. Quality of life in schizophrenia: insight and subjective response to neuroleptics. Journal of Nervous and Mental Disease 1998; 186: 74–78.

    Article  PubMed  CAS  Google Scholar 

  120. Lysaker PH, Bell MD, Bryson GJ, Kaplan E. Insight and interpersonal function in schizophrenia. Journal of Nervous and Mental Disease 1998; 186: 432–436.

    Article  PubMed  CAS  Google Scholar 

  121. Zeitlhofer J, Schmeiser-Rieder A, Tribl G, et al. Sleep and quality of life in the Austrian population. Acta Neurologica Scandinavica 2000; 102: 249–257.

    Article  PubMed  CAS  Google Scholar 

  122. Leger D, Scheuermaier K, Philip P, et al. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosomatic Medicine 2001; 63: 49–55.

    PubMed  CAS  Google Scholar 

  123. Doi Y, Minowa M, Okawa M, Uchiyama M. Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population. Journal of Epidemiology 2000; 10: 79–86.

    PubMed  CAS  Google Scholar 

  124. Benca, RM. Consequences of insomnia and its therapies. Journal of Clinical Psychiatry 2001; 62 (Suppl 10): S33-S38.

    Google Scholar 

  125. Rosch PJ. Stress and sleep: some startling and sobering statistics. Stress Medicine 1996; 12: 207–210.

    Article  Google Scholar 

  126. Singareddy RK, Balon R. Sleep and suicide in psychiatric patients. Annals of Clinical Psychiatry 2001; 13: 93–101.

    Article  PubMed  CAS  Google Scholar 

  127. Harris EC, Barraclough B. Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry 1997; 170: 205–228.

    PubMed  CAS  Google Scholar 

  128. Harkavy-Friedman JM, Resifo K, et al. Suicidal behavior in schizophrenia: characteristics of individuals who had and had not attempted suicide. Am J Psychiatry 1999; 156: 1276–1278.

    PubMed  CAS  Google Scholar 

  129. Koivumaa-Honkanen HT, Honkanen R, Viinamaki H, et al. Life satisfaction and suicide: a 20-year follow-up study. Am J Psychiatry 2001; 158: 433–439.

    Article  PubMed  CAS  Google Scholar 

  130. Wiersma D, Nienhuis FJ, Giel R, Slooff CJ. Stability and change in needs of patients with schizophrenic disorders: a 15- and 17-year follow-up from first onset of psychosis, and a comparison between ’objective’ and ’subjective’ assessments of needs for care. Soc Psychiatry Psychiatr Epidemiol. 1998; 33: 49–56.

    Article  PubMed  CAS  Google Scholar 

  131. Slade M, Leese M, Ruggeri M, et al. Does meeting needs improve quality of life? Psychother Psychosom. 2004; 73: 183–189.

    Article  PubMed  Google Scholar 

  132. Thornicroft G, Tansella M, Becker T, et al. EPSILON Study Group. The personal impact of schizophrenia in Europe. Schizophr Res. 2004; 69: 125–132.

    Google Scholar 

  133. Korkeila J, Heikkila J, Hansson L, et al. Structure of needs among persons with schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2005; 40: 233–9.

    Article  PubMed  Google Scholar 

  134. Barry MM, Crosby C. Quality of life as an evaluative measure in assessing the impact of community care on people with long-term psychiatric disorders. Br J Psychiatry. 1996; 168: 210–6.

    PubMed  CAS  Google Scholar 

  135. Brekke JS, Kohrt B, Green MF. Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. Schizophr Bull. 2001; 27: 697–708.

    PubMed  CAS  Google Scholar 

  136. Becker T, Leese M, Krumm S, et al. EPSILON Study Group.Needs and quality of life among patients with schizophrenia in five European centres: what is the impact of global functioning scores? Soc Psychiatry Psychiatr Epidemiol. 2005; 40: 628–634.

    Article  PubMed  Google Scholar 

  137. Priebe S, Warner R, Hubschmid T, Eckle I. Employment, attitudes toward work, and quality of life among people with schizophrenia in three countries. Schizophr Bull 1998; 24: 469–77.

    PubMed  CAS  Google Scholar 

  138. Eklund M, Hansson L, Bejerholm U. Relationships between satisfaction with occupational factors and health-related variables in schizophrenia outpatients. Soc Psychiatry Psychiatr Epidemiol. 2001; 36: 79–83.

    Article  PubMed  CAS  Google Scholar 

  139. Bond GR, Resnick SG, Drake RE, et al. Does competitive employment improve nonvocational outcomes for people with severe mental illness? J Consult Clin Psychol. 2001; 69: 489–501.

    Article  PubMed  CAS  Google Scholar 

  140. Marwaha S, Johnson S. Schizophrenia and employment - a review. Soc Psychiatry Psychiatr Epidemiol. 2004; 39:337-349.

    Article  PubMed  Google Scholar 

  141. Kaiser W, Priebe S, Barr W, et al. Profiles of subjective quality of life in schizophrenic in- and out-patient samples. Psychiatry Research 1997; 66: 153–66.

    Article  PubMed  CAS  Google Scholar 

  142. Franz M, Meyer T, Reber T, Gallhofer B. The importance of social comparisons for high levels of subjective quality of life in chronic schizophrenic patients. Qual Life Res. 2000; 9: 481–9.

    Article  PubMed  CAS  Google Scholar 

  143. Hobbs C, Tennant C, Rosen A, et al. Deinstitutionalisation for long-term mental illness: a 2-year clinical evaluation. Aust N Z J Psychiatry. 2000; 34: 476–83.

    Article  PubMed  CAS  Google Scholar 

  144. Lehman AF, Possidente S, Hawker F. The quality of life of chronic patients in a state hospital and in community residences. Hosp Community Psychiatry 1986; 37: 901–7.

    PubMed  CAS  Google Scholar 

  145. Kemmler G, Meise U, Tasser A. [Subjective quality of life of schizophrenic patients. Effect of treatment setting, psychopathology and extrapyramidal motor drug effects] Psychiatrische Praxis 1999; 26: 9–15.

    PubMed  CAS  Google Scholar 

  146. Rossler W, Salize HJ, Cucchiaro G, et al. Does the place of treatment influence the quality of life of schizophrenics? Acta Psychiatr Scand. 1999; 100: 142–148.

    PubMed  CAS  Google Scholar 

  147. Malla A, Williams R, Kopala L, et al. Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders. Acta Psychiatr Scand. 2006 ; 113:22–28.

    Article  Google Scholar 

  148. Revicki DA, Genduso LA, Hamilton SH, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial. Qual Life Res 1999; 8: 417–426.

    Article  PubMed  CAS  Google Scholar 

  149. Rovner J, Assuncao S, Gargoloff P, et al.[Functional status and quality of life in Latin American outpatients with schizophrenia treated with atypical or typical antipsychotics: outcomes of the 12 months schizophrenia outpatient health outcomes (IC-SOHO) Study]. Vertex. 2005; 16:332-41 [Article in Spanish].

    PubMed  Google Scholar 

  150. Beasley CM Jr,Sutton VK, Taylor CC, et al. Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment? J Clin Psychopharmacol. 2006; 26: 40–44.

    Article  PubMed  Google Scholar 

  151. Mayoral F, Montejo A, Bousono M, et al. Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 year follow-up naturalistic study. Actas Esp Psiquiatr. 2006; 34: 7–15.

    PubMed  CAS  Google Scholar 

  152. Rosenheck R, Perlick D, Bingham S, et al. Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA. 2003; 290: 2693–702.

    Article  PubMed  CAS  Google Scholar 

  153. Strakowski SM, Johnson JL, Delbello MP, et al. Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. Schizophr Res. 2005; 78: 161–169.

    Article  PubMed  Google Scholar 

  154. Gureje O, Miles W, Keks N, et al. Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand. Schizophr Res 2003; 61: 303–314.

    Article  PubMed  Google Scholar 

  155. Ho BC, Nopoulos P, Flaum M, et al. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. American Journal of Psychiatry 1998; 155: 1196–1201.

    PubMed  CAS  Google Scholar 

  156. Werneke U, Turner T, Priebe S. Complementary medicines in psychiatry: review of effectiveness and safety. Br J Psychiatry. 2006; 188: 109–21.

    Article  PubMed  Google Scholar 

  157. Aasen I, Kumari V, Sharma T. Effects of rivastigmine on sustained attention in schizophrenia: an FMRI study. J Clin Psychopharmacol. 2005; 25: 311–7.

    Article  PubMed  CAS  Google Scholar 

  158. Lenzi A, Maltinti E, Poggi E, et al. Effects of rivastigmine on cognitive function and quality of life in patients with schizophrenia. Clin Neuropharmacol. 2003; 26:317–21.

    Article  PubMed  CAS  Google Scholar 

  159. Peet M, Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs. 2005; 65: 1051–1059.

    Article  PubMed  CAS  Google Scholar 

  160. Arvindakshan M, Ghate M, Ranjekar PK, et al. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res. 2003; 62: 195–204.

    Article  PubMed  Google Scholar 

  161. Rosenthal MH, Bryant SL. Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia. Clin Neuropharmacol. 2004; 27: 38–43.

    Article  PubMed  CAS  Google Scholar 

  162. Becker PM, Schwartz JR, Feldman NT, Hughes RJ. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology (Berl). 2004; 171: 133–9.

    Article  CAS  Google Scholar 

  163. Ritsner M, Maayan R, Gibel A, et al. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. European Neuropsychopharmacology 2004; 14: 267–273.

    Article  PubMed  CAS  Google Scholar 

  164. Ritsner M, Gibel A, Maayan R, et al. Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia. Neuropsychopharmacology. 2005; 30: 1913–22.

    Article  PubMed  CAS  Google Scholar 

  165. Ritsner M, Gibel A, Ram E, et al. Alterations in DHEA metabolism in schizophrenia: two-month case-control study. Eur Neuropsychopharmacol. 2006; 16: 137–146.

    Article  PubMed  CAS  Google Scholar 

  166. Ritsner, MS., Gibel, A., Ratner, Y., et al. Improvement of Sustained Attention, Visual and Movement Skills, but not Clinical Symptomatology, following Dehydroepiandrosterone Augmentation in Schizophrenia: a randomized double-blind, placebo-controlled, crossover trial. Journal of Clinical Psychopharmacology 2006; 26:495–499.

    Article  PubMed  CAS  Google Scholar 

  167. Voruganti LN, Heslegrave RJ, Awad AG. Quality of life measurement during antipsychotic drug therapy of schizophrenia. Journal of Psychiatry and Neuroscience 1997; 22: 267–274.

    PubMed  CAS  Google Scholar 

  168. Dernovsek MZ, Prevolnik Rupel V, Rebolj M, Tavcar R. Quality of life and treatment costs in schizophrenic outpatients, treated with depot neuroleptics. European Psychiatry 2001; 16: 474–482.

    Article  PubMed  CAS  Google Scholar 

  169. Browne S, Roe M, Lane A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand. 1996; 94: 118–124.

    PubMed  CAS  Google Scholar 

  170. Gerlach J, Larsen EB. Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatrica Scandinavica Supplementum 1999; 395: 113–117.

    PubMed  CAS  Google Scholar 

  171. Allison DB, Mackell JA, McDonnell DD. The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr Serv. 2003; 54: 565–567.

    Article  PubMed  Google Scholar 

  172. Olfson M, Uttaro T, Carson WH, Tafesse E. Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry. 2005; 66: 331–338.

    Article  PubMed  Google Scholar 

  173. Wirshing DA, Pierre JM, Marder SR, et al. Sexual side effects of novel antipsychotic medications. Schizophr Res. 2002; 56: 25–30.

    Article  PubMed  Google Scholar 

  174. Skantze K. Malm U, Dencker S, et al. Comparison of quality of life with standard of living in schizophrenic outpatients. Br J Psychiatry 1992; 161: 797–801.

    Article  PubMed  CAS  Google Scholar 

  175. Vandiver VL. Quality of life, gender and schizophrenia: a cross-national survey in Canada, Cuba, and U.S.A. Community Ment Health J 1998; 34: 501–11.

    Article  PubMed  CAS  Google Scholar 

  176. Jarema, M., Konieczynska, Z. Quality of life in schizophrenia: Impact of psychopathology, patients’ gender and antipsychotic treatment. Int J Psych Clin Pract 2001; 5:19–26.

    Google Scholar 

  177. Patterson TL, Shaw W, Semple SJ, et al. Health-related quality of life in older patients with schizophrenia and other psychoses: relationships among psychosocial and psychiatric factors. Int J Geriatr Psychiatry. 1997; 12:452–461.

    Article  PubMed  CAS  Google Scholar 

  178. [No authors listed] Predictors of quality of life in people with severe mental illness. Study methodology with baseline analysis in the UK700 trial. British Journal of Psychiatry, 1999; 175: 426–432.

    Google Scholar 

  179. Bechdolf A, Klosterkotter J, Hambrecht M, et al. Determinants of subjective quality of life in post acute patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2003; 253:235.

    Google Scholar 

  180. Chan PS, Krupa T, Lawson JS, Eastabrook S. An outcome in need of clarity: building a predictive model of subjective quality of life for persons with severe mental illness living in the community. Am J Occup Ther. 2005; 59:181–190.

    PubMed  Google Scholar 

  181. Ruggeri M, Nose M, Bonetto C, et al. Changes and predictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice. Br J Psychiatry. 2005; 187:121–130.

    Article  PubMed  Google Scholar 

  182. Gaite L, Vazquez-Barquero JL, Borra C, et al. The EPSILON Study Group. Quality of life in patients with schizophrenia in five European countries: the EPSILON study. Acta Psychiatrica Scandinavica 2002; 105:283–292.

    Article  PubMed  CAS  Google Scholar 

  183. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacology Bulletin 1993; 29:321–326.

    PubMed  CAS  Google Scholar 

  184. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC, 1994.

    Google Scholar 

  185. Kay, S.R., Fiszbein, A., Opler, L.A., The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987; 13:261–276.

    PubMed  CAS  Google Scholar 

  186. White L, Harvey PD, Opler L, Lindenmayer JP. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology 1997; 30:263–274.

    CAS  Google Scholar 

  187. Lancon C, Aghababian V, Llorca PM, Auquier P. Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysis. Acta Psychiatrica Scandinavica 1998; 98: 369–376.

    PubMed  CAS  Google Scholar 

  188. Lindenmayer JP, Bernstein-Hyman R, Grochowski S. Five-factor model of schizophrenia. Initial validation. Journal of Nervous and Mental Disease 1994; 182: 631–638.

    Article  CAS  Google Scholar 

  189. Mohr PE, Cheng CM, Claxton K, et al. The heterogeneity of schizophrenia in disease states. Schizophrenia Research 2004; 71: 83–95.

    Article  PubMed  Google Scholar 

  190. McEvoy JP, Freter S, Everett G, et al. Insight and the clinical outcome of schizophrenic patients. Journal of Nervous and Mental Disease 1989; 177: 48–51.

    Article  PubMed  CAS  Google Scholar 

  191. Birchwood M, Smith J, Drury V, et al. A Self-Report Insight Scale for Psychosis: Reliability, Validity and Sensitivity to Change. Acta Psychiatrica Scandinavica 1994; 89: 62–67.

    PubMed  CAS  Google Scholar 

  192. Ritsner M, Rabinowitz J, Slyuzberg M. The Talbieh Brief Distress Inventory: a brief instrument to measure psychological distress among immigrants. Comprehensive Psychiatry 1995; 36: 448–453.

    Article  PubMed  CAS  Google Scholar 

  193. Ritsner M, Ponizovsky A. Psychological symptoms among immigrant population: a prevalence study. Compr Psychiatry 1998; 39: 21–27.

    Article  PubMed  CAS  Google Scholar 

  194. Derogatis LR, Spencer PM. The Brief Symptom Inventory (BSI): Administration, Scoring and Procedures Manual. Johns Hopkins University, School of Medicine; 1982.

    Google Scholar 

  195. Rosenberg M. Society and the Adolescent Self-image. Princeton, NJ: Princeton University Press;1965.

    Google Scholar 

  196. Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support. Journal of Personality Assessment 1988; 52: 30–41.

    Article  Google Scholar 

  197. Cole JD, Kazarian SS. The level of expressed emotion scale: a new measure of expressed emotion. Journal of Clinical Psychology 1988; 44: 392–397.

    Article  PubMed  CAS  Google Scholar 

  198. Cole JD, Kazarian SS. Predictive validity of the Level of Expressed Emotion (LEE) Scale: readmission follow-up data for 1, 2, and 5-year periods. J Clin Psychol. 1993; 49: 216–8.

    Article  PubMed  CAS  Google Scholar 

  199. Cloninger CR A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987; 44: 573–588.

    PubMed  CAS  Google Scholar 

  200. Hintze, JL. NCSS 2000 Statistical System for Windows. User’s Guide. Number Cruncher Statistical Systems: Kaysville, Utah, 2000.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry The Rappaport Faculty of Medicine, Technion - Israel Institute of Technology and Acute Department, Sha’ar Menashe Mental Health Center, Israel

    Michael S. Ritsner & Anatoly Gibel

Authors
  1. Michael S. Ritsner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anatoly Gibel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Associate Professor, Department of Psychiatry, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa

    Michael S. Ritsner

  2. Director, Acute Department, Sha’ar Menashe, Mental Health Center, Israel

    Michael S. Ritsner

  3. Associate Editor, Quality of Life Research, Amsterdam, The Netherlands

    Michael S. Ritsner

  4. Professor Emeritus, Department of Psychiatry, Institute of Medical Science University of Toronto Chief of Psychiatry, Humber River Regional Hospital, Toronto

    A. George Awad

  5. Ontario President, The International Society of CNS, Clinical Trials and Methodology, Canada

    A. George Awad

Rights and permissions

Reprints and permissions

Copyright information

© 2007 springer

About this chapter

Cite this chapter

Ritsner, M.S., Gibel, A. (2007). Quality of life impairment syndrome in schizophrenia. In: Ritsner, M.S., Awad, A.G. (eds) Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5779-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4020-5779-3_10

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-5777-9

  • Online ISBN: 978-1-4020-5779-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation